Abstract
Article1 November 1962Large Doses of Prednisone and Prednisolone in the Treatment of Malignant Lymphoproliferative DisordersROBERT A. KYLE, M.D., CLIFTON E. MCPARLAND, M.D., WILLIAM DAMESHEK, M.D., F.A.C.P.ROBERT A. KYLE, M.D.Search for more papers by this author, CLIFTON E. MCPARLAND, M.D.Search for more papers by this author, WILLIAM DAMESHEK, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-57-5-717 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTreatment of the generalized chronic malignant lymphoproliferative disorders*is not standardized at all. In asymptomatic chronic lymphocytic leukemia, the best treatment is often no treatment. In the "aggressive" cases of chronic lymphocytic leukemia (1) and in generalized or disseminated lymphosarcomatosis, one of several therapeutic programs may be preferred. These include treatment with roentgen rays, nitrogen mustard, or one of the other alkylating agents [triethylene melamine (TEM), chlorambucil (Leukeran), or cyclophosphamide (Cytoxan)]; and corticosteroids. Each form of therapy has its adherents, and each may be said to have a special value in some phases of the patient's illness. In the last...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
